Latest Euronext Stories
AMSTERDAM, July 13, 2012 /PRNewswire/ -- Amsterdam Molecular Therapeutics (AMT) Holding NV (in liquidation) (Euronext: AMT) published its Annual Report and Accounts for the year ended December 31, 2011 and announced that it will host its Annual General Meeting at its headquarters (Meibergdreef 61, 1105 BA Amsterdam Zuidoost, the Netherlands) at 14.00 hrs on September 12, 2012. Shareholders of the dissolved company are invited to attend. For further details, agenda and...
LEUVEN, Belgium, July 12, 2012 /PRNewswire/ -- ThromboGenics NV (NYSE Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces that it has received a transparency declaration from Fidelity Management & Research Company LLC in accordance with the Belgian Law of 2 May 2007 concerning disclosure of major holdings in issuers whose shares are admitted to trading on a Belgian regulated market. ThromboGenics NV...
JERSEY CITY, N.J., July 12, 2012 /PRNewswire/ -- Knight Capital Group, Inc. (NYSE Euronext: KCG) today announced that Knight Hotspot FX received a 2012 e-FX Award for "Best Professional e-Trading Venue" from FX Week, the second consecutive year for Knight's institutional foreign exchange ECN. "The Knight Hotspot FX team is honored that FX Week once again named our institutional FX ECN the Best Professional e-Trading Platform in the 2012 e-FX Awards," said John Miesner, Managing...
JOHANNESBURG, July 4, 2012 /PRNewswire/ -- Gold Fields Limited (Gold Fields) (JSE, NYSE, NASDAQ Dubai: GFI) is pleased to report that the eleven people admitted to hospital for observation following a fire at the KDC mine over the weekend, have been released. The proto teams continue to work at the KDC West Ya Rona shaft to extinguish the fire that is burning at around 2,800 meters below surface in a worked-out area between 38 and 39 levels. KDC West remains...
BELLEVUE, Wash., June 28, 2012 /PRNewswire/ -- Radiant Logistics, Inc. (NYSE MKT: RLGT), a domestic and international transportation and logistics services company, is pleased to announce that it will ring The Opening Bell at the New York Stock Exchange (NYSE) on Friday, July 6th, 2012, to commemorate the Company's recent listing on the NYSE MKT. Radiant's common stock began trading on the NYSE exchange on January 11th, 2012 and was also recently added to the Russell Microcap...
LONDON, June 14, 2012 /PRNewswire/ -- Royal Dutch Shell plc ("Shell") (NYSE: RDS.A)(NYSE: RDS.B) announces that application has been made to the UK Listing Authority and the London Stock Exchange for 19,764,839 A Ordinary shares of Eur 0.07 each in the capital of Shell (the "shares") to be admitted to the Official List of the United Kingdom Listing Authority and to be traded on the main market of the London Stock Exchange. Application will also be made to Euronext Amsterdam...
NIEUWEGEIN, The Netherlands, June 7, 2012 /PRNewswire/ -- The Dutch Public Prosecutor's Office and the Fiscal Information and Investigation Service (FIOD) are conducting a criminal investigation against Ballast Nedam as a suspect related to payments to foreign agents in the period of 1996 - 2004. Ballast Nedam has brought this matter to the attention of the Public Prosecutor's Office in January 2011. As stated in the press release of 21 January 2011 Ballast Nedam...
LEUVEN, Belgium, June 7, 2012 /PRNewswire/ -- Meeting scheduled for 26 July 2012 ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs...
NIEUWEGEIN, The Netherlands, May 16, 2012 /PRNewswire/ -- On 16 May 2012 the Annual General Meeting of Shareholders of Ballast Nedam took place. A cash dividend of EUR 0.47 per share outstanding for 2011 was established. The share Ballast Nedam will be listed ex-dividend on 18 May 2012. The record date for dividend entitlement is 22 May 2012 and the payment of the dividend will take effect on 29 May 2012. Furthermore Mr A.N.A.M. Smits has been reappointed to the...
LEUVEN, Belgium, May 10, 2012 /PRNewswire/ -- Regulated Information Disclosure in accordance with the law of May 2, 2007 ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today issued a business update and its first-quarter financial results for the period ending 31 March 2012. Highlights (including post-quarter events) Ocriplasmin - ThromboGenics signed...
